Related references
Note: Only part of the references are listed.JAK inhibitors in difficult-to-treat adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis
Louise Gillard et al.
RHEUMATOLOGY (2023)
Improvement of Refractory Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease with Single-Agent Blockade of IL-1β and IL-18
Julia E. Rood et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2023)
Effectiveness and safety of ruxolitinib for the treatment of refractory systemic idiopathic juvenile arthritis like associated with interstitial lung disease : a case report
Brigitte Bader-Meunier et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1*15 alleles
Vivian E. Saper et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist
Micol Romano et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Expansion of CD4dimCD8+ T cells characterizes macrophage activation syndrome and other secondary HLH
Arianna De Matteis et al.
BLOOD (2022)
Role for Granulocyte Colony-Stimulating Factor in Neutrophilic Extramedullary Myelopoiesis in a Murine Model of Systemic Juvenile Idiopathic Arthritis
Bert Malengier-Devlies et al.
ARTHRITIS & RHEUMATOLOGY (2022)
The Conundrum of Lung Disease and Drug Hypersensitivity-like Reactions in Systemic Juvenile Idiopathic Arthritis
Bryce A. Binstadt et al.
ARTHRITIS & RHEUMATOLOGY (2022)
mTORC1 links pathology in experimental models of Still's disease and macrophage activation syndrome
Zhengping Huang et al.
NATURE COMMUNICATIONS (2022)
The Big Bad Wolf: Macrophage Activation Syndrome in Childhood-Onset Systemic Lupus Erythematosus
Grant S. Schulert
JOURNAL OF RHEUMATOLOGY (2022)
Monocyte and bone marrow macrophage transcriptional phenotypes in systemic juvenile idiopathic arthritis reveal TRIM8 as a mediator of IFN-γ hyper-responsiveness and risk for macrophage activation syndrome
Grant S. Schulert et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
T-cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsis
Vandana Chaturvedi et al.
BLOOD (2021)
Pathology of macrophage activation syndrome in humanized NSGS mice
James C. Tarrant et al.
RESEARCH IN VETERINARY SCIENCE (2021)
Clinical significance of interleukin-18 for the diagnosis and prediction of disease course in systemic juvenile idiopathic arthritis
Mao Mizuta et al.
RHEUMATOLOGY (2021)
Amelioration of Murine Macrophage Activation Syndrome by Monomethyl Fumarate in Both a Heme Oxygenase 1-Dependent and Heme Oxygenase 1-Independent Manner
Chhanda Biswas et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Targeting interferon-γ in hyperinflammation: opportunities and challenges
Fabrizio De Benedetti et al.
NATURE REVIEWS RHEUMATOLOGY (2021)
Lung Functioning and Inflammation in a Mouse Model of Systemic Juvenile Idiopathic Arthritis
Bert Malengier-Devlies et al.
FRONTIERS IN IMMUNOLOGY (2021)
Monocytes From Patients With Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis Are Hyperresponsive to Interferon Gamma
Antonia Pascarella et al.
FRONTIERS IN IMMUNOLOGY (2021)
Pathogenesis and Treatment of Refractory Disease Courses in Systemic Juvenile Idiopathic Arthritis Refractory Arthritis, Recurrent Macrophage Activation Syndrome and Chronic Lung Disease
Remco Erkens et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2021)
IFN-γ is essential for alveolar macrophage driven pulmonary inflammation in macrophage activation syndrome -
Denny K. Gao et al.
JCI INSIGHT (2021)
IL-18 as therapeutic target in a patient with resistant systemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome
Shima Yasin et al.
RHEUMATOLOGY (2020)
IL-18 as a biomarker linking systemic juvenile idiopathic arthritis and macrophage activation syndrome
Shima Yasin et al.
RHEUMATOLOGY (2020)
Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis
Esraa M. Eloseily et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis
F. Locatelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Line-selective macrophage activation with an anti-CD40 antibody drives a hemophagocytic syndrome in mice
Giada Ingoglia et al.
BLOOD ADVANCES (2020)
Production of IL-18 Binding Protein by Radiosensitive and Radioresistant Cells in CpG-Induced Macrophage Activation Syndrome
Mathilde Harel et al.
JOURNAL OF IMMUNOLOGY (2020)
EMAPALUMAB (ANTI-INTERFERON-GAMMA MONOCLONAL ANTIBODY) IN PATIENTS WITH MACROPHAGE ACTIVATION SYNDROME (MAS) COMPLICATING SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA)
F. De Benedetti et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Clinical significance of serum CXCL9 levels as a biomarker for systemic juvenile idiopathic arthritis associated macrophage activation syndrome
Mao Mizuta et al.
CYTOKINE (2019)
Emergent high fatality lung disease in systemic juvenile arthritis
Vivian E. Saper et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Brief Report: Interferon-γ-Mediated Immunopathology Potentiated by Toll-Like Receptor 9 Activation in a Murine Model of Macrophage Activation Syndrome
Lehn K. Weaver et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
Maiko Takakura et al.
CLINICAL IMMUNOLOGY (2019)
Regulatory Role for NK Cells in a Mouse Model of Systemic Juvenile Idiopathic Arthritis
Jessica Vandenhaute et al.
JOURNAL OF IMMUNOLOGY (2019)
Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease: Characterization and Risk Factors
Grant S. Schulert et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus
Alberto Martini et al.
JOURNAL OF RHEUMATOLOGY (2019)
Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease
Cem Gabay et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Unopposed IL-18 signaling leads to severe TLR9-induced macrophage activation syndrome in mice
Charlotte Girard-Guyonvarc'h et al.
BLOOD (2018)
Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome
Eric S. Weiss et al.
BLOOD (2018)
Neutralization of IFN-γ reverts clinical and laboratory features in a mouse model of macrophage activation syndrome
Giusi Prencipe et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Features, Treatment, and Outcomes of Macrophage Activation Syndrome in Childhood-Onset Systemic Lupus Erythematosus
R. Ezequiel Borgia et al.
ARTHRITIS & RHEUMATOLOGY (2018)
IL1RN Variation Influences Both Disease Susceptibility and Response to Recombinant Human Interleukin-1 Receptor Antagonist Therapy in Systemic Juvenile Idiopathic Arthritis
Victoria L. Arthur et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Insufficient IL-10 Production as a Mechanism Underlying the Pathogenesis of Systemic Juvenile Idiopathic Arthritis
Maya Imbrechts et al.
JOURNAL OF IMMUNOLOGY (2018)
Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
Claudia Bracaglia et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
IL-10 distinguishes a unique population of activated, effector-like CD8+ T cells in murine acute liver inflammation
Julia E. Rood et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2017)
Kawasaki Disease Complicated With Macrophage Activation Syndrome: A Systematic Review
Susana Garcia-Pavon et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2017)
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
J.-F. Emile et al.
BLOOD (2016)
Altered signaling in systemic juvenile idiopathic arthritis monocytes
Claudia Macaubas et al.
CLINICAL IMMUNOLOGY (2016)
Mouse Cytomegalovirus Infection in BALB/c Mice Resembles Virus-Associated Secondary Hemophagocytic Lymphohistiocytosis and Shows a Pathogenesis Distinct from Primary Hemophagocytic Lymphohistiocytosis
Ellen Brisse et al.
JOURNAL OF IMMUNOLOGY (2016)
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
Angelo Ravelli et al.
ARTHRITIS & RHEUMATOLOGY (2016)
A xenograft model of macrophage activation syndrome amenable to anti-CD33 and anti-IL-6R treatment
Mark Wunderlich et al.
JCI INSIGHT (2016)
S100A8/A9, a potent serum and molecular imaging biomarker for synovial inflammation and joint destruction in seronegative experimental arthritis
Edwin J. W. Geven et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Pathogenesis of Macrophage Activation Syndrome and Potential for Cytokine-Directed Therapies
Grant S. Schulert et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis
Masaki Shimizu et al.
CLINICAL IMMUNOLOGY (2015)
Successful control of juvenile dermatomyositis-associated macrophage activation syndrome and interstitial pneumonia: distinct kinetics of interleukin-6 and-18 levels
Hiroyuki Wakiguchi et al.
PEDIATRIC RHEUMATOLOGY (2015)
Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-gamma
Karen Put et al.
RHEUMATOLOGY (2015)
Macrophage activation syndrome in Kawasaki Disease: More common than we thought?
Wei Wang et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)
Inhibition of Natural Killer Cell Cytotoxicity by Interleukin-6: Implications for the Pathogenesis of Macrophage Activation Syndrome
Loredana Cifaldi et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Pathogenesis of adult-onset Still's disease: new insights from the juvenile counterpart
Yvan Jamilloux et al.
IMMUNOLOGIC RESEARCH (2015)
Simultaneous Targeting of IL-1 and IL-18 Is Required for Protection against Inflammatory and Septic Shock
Tom Vanden Berghe et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation
Neil Romberg et al.
NATURE GENETICS (2014)
An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome
Scott W. Canna et al.
NATURE GENETICS (2014)
Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis A Multinational, Multicenter Study of 362 Patients
Francesca Minoia et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Whole-Exome Sequencing Reveals Overlap Between Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis and Familial Hemophagocytic Lymphohistiocytosis
Kenneth M. Kaufman et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Systemic Juvenile Idiopathic Arthritis-like Syndrome in Mice Following Stimulation of the Immune System With Freund's Complete Adjuvant Regulation by Interferon-γ
Anneleen Avau et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Interferon-γ Mediates Anemia but Is Dispensable for Fulminant Toll-like Receptor 9-Induced Macrophage Activation Syndrome and Hemophagocytosis in Mice
Scott W. Canna et al.
ARTHRITIS AND RHEUMATISM (2013)
Enhanced normal short-term human myelopoiesis in mice engineered to express human-specific myeloid growth factors
Paul H. Miller et al.
BLOOD (2013)
Pulmonary Hypertension and Other Potentially Fatal Pulmonary Complications in Systemic Juvenile Idiopathic Arthritis
Yukiko Kimura et al.
ARTHRITIS CARE & RESEARCH (2013)
Graded defects in cytotoxicity determine severity of hemophagocytic lymphohistiocytosis in humans and mice
Birthe Jessen et al.
FRONTIERS IN IMMUNOLOGY (2013)
The Toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis
Dirk Holzinger et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Amplification of the response to toll-like receptor ligands by prolonged exposure to interleukin-6 in mice: Implication for the pathogenesis of macrophage activation syndrome
Raffaele Strippoli et al.
ARTHRITIS AND RHEUMATISM (2012)
The limited role of interferon-γ in systemic juvenile idiopathic arthritis cannot be explained by cellular hyporesponsiveness
Keith A. Sikora et al.
ARTHRITIS AND RHEUMATISM (2012)
Compensated inflammation in systemic juvenile idiopathic arthritis: Role of alternatively activated macrophages
Masaki Shimizu et al.
CYTOKINE (2012)
Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis
Fabrizio De Benedetti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis
Sebastiaan J. Vastert et al.
RHEUMATOLOGY (2010)
Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis
Masaki Shimizu et al.
RHEUMATOLOGY (2010)
Defective Phosphorylation of Interleukin-18 Receptor β Causes Impaired Natural Killer Cell Function in Systemic-Onset Juvenile Idiopathic Arthritis
Wilco de Jager et al.
ARTHRITIS AND RHEUMATISM (2009)
An Autoinflammatory Disease with Deficiency of the Interleukin-1-Receptor Antagonist
Ivona Aksentijevich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
S100A12 Is a Novel Molecular Marker Differentiating Systemic-Onset Juvenile Idiopathic Arthritis From Other Causes of Fever of Unknown Origin
Helmut Wittkowski et al.
ARTHRITIS AND RHEUMATISM (2008)
Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms
Kejian Zhang et al.
ARTHRITIS AND RHEUMATISM (2008)
Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome
Ndate Fall et al.
ARTHRITIS AND RHEUMATISM (2007)
The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor α-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis
Jack Bleesing et al.
ARTHRITIS AND RHEUMATISM (2007)
HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
Jan-Inge Henter et al.
PEDIATRIC BLOOD & CANCER (2007)
Impaired skeletal development in interleukin-6-transgenic mice - A model for the impact of chronic inflammation on the growing skeletal system
Fabrizio De Benedetti et al.
ARTHRITIS AND RHEUMATISM (2006)
Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2Rγnull mice engrafted with mobilized human hemopoietic stem cells
LD Shultz et al.
JOURNAL OF IMMUNOLOGY (2005)
Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
A Ravelli et al.
JOURNAL OF PEDIATRICS (2005)
Macrophage activation syndrome:: characteristic findings on liver biopsy illustrating the key role of activated, IFN-γ-producing lymphocytes and IL-6- and TNF-α-producing macrophages
AD Billiau et al.
BLOOD (2005)
Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome
J Villanueva et al.
ARTHRITIS RESEARCH & THERAPY (2005)
An animal model of hemophagocytic lymphohistiocytosis (HLH):: CD8+ T cells and interferon gamma are essential for the disorder
MB Jordan et al.
BLOOD (2004)
Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome
AA Grom et al.
JOURNAL OF PEDIATRICS (2003)
Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice
R Horai et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
